At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 152 enrolled
Drug / intervention
T4020 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
In Brief
A Phase 3 clinical trial evaluating T4020 and Vehicle for Keratitis and Corneal Ulcer. Completed, enrolled 152 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKeratitis, Corneal Ulcer
CountriesFrance
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionDec 2017
TodayJul 2026
First PostedFeb 18, 2013
Enrollment StartFeb 1, 2013
Primary CompletionDec 19, 2017
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 13.4 years ago
Interventions
T4020device
Vehicledevice